Royal Bank of Canada’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2K Buy
6,778
+1,004
+17% +$296 ﹤0.01% 6427
2025
Q1
$1K Buy
5,774
+4,077
+240% +$706 ﹤0.01% 6309
2024
Q4
$1K Sell
1,697
-3,465
-67% -$2.04K ﹤0.01% 6313
2024
Q3
$6K Sell
5,162
-377
-7% -$438 ﹤0.01% 5995
2024
Q2
$4K Buy
5,539
+3,283
+146% +$2.37K ﹤0.01% 6213
2024
Q1
$7K Sell
2,256
-21,123
-90% -$65.5K ﹤0.01% 5897
2023
Q4
$75K Buy
23,379
+10,560
+82% +$33.9K ﹤0.01% 5252
2023
Q3
$49K Buy
12,819
+6,598
+106% +$25.2K ﹤0.01% 5307
2023
Q2
$20K Buy
6,221
+6,164
+10,814% +$19.8K ﹤0.01% 5758
2023
Q1
$0 Buy
57
+1
+2% ﹤0.01% 6851
2022
Q4
$0 Sell
56
-403
-88% ﹤0.01% 7031
2022
Q3
$1K Buy
+459
New +$1K ﹤0.01% 6742
2022
Q2
Sell
-960
Closed -$3K 7058
2022
Q1
$3K Sell
960
-540
-36% -$1.69K ﹤0.01% 6903
2021
Q4
$5K Sell
1,500
-6,000
-80% -$20K ﹤0.01% 6688
2021
Q3
$25K Sell
7,500
-17,221
-70% -$57.4K ﹤0.01% 6057
2021
Q2
$97K Sell
24,721
-50,101
-67% -$197K ﹤0.01% 5150
2021
Q1
$301K Sell
74,822
-7,479
-9% -$30.1K ﹤0.01% 4145
2020
Q4
$190K Sell
82,301
-337,290
-80% -$779K ﹤0.01% 4367
2020
Q3
$2.41M Buy
419,591
+299,101
+248% +$1.72M ﹤0.01% 2201
2020
Q2
$888K Buy
120,490
+113,366
+1,591% +$835K ﹤0.01% 2878
2020
Q1
$21K Buy
7,124
+454
+7% +$1.34K ﹤0.01% 5023
2019
Q4
$28K Buy
6,670
+3,314
+99% +$13.9K ﹤0.01% 5118
2019
Q3
$11K Sell
3,356
-799
-19% -$2.62K ﹤0.01% 5122
2019
Q2
$8K Buy
4,155
+2,000
+93% +$3.85K ﹤0.01% 5247
2019
Q1
$4K Sell
2,155
-54
-2% -$100 ﹤0.01% 5373
2018
Q4
$5K Sell
2,209
-277
-11% -$627 ﹤0.01% 5321
2018
Q3
$14K Buy
2,486
+544
+28% +$3.06K ﹤0.01% 5245
2018
Q2
$16K Sell
1,942
-850
-30% -$7K ﹤0.01% 5064
2018
Q1
$20K Buy
+2,792
New +$20K ﹤0.01% 4845
2017
Q4
Sell
-329
Closed -$3K 5955
2017
Q3
$3K Buy
329
+323
+5,383% +$2.95K ﹤0.01% 5753
2017
Q2
$0 Buy
+6
New ﹤0.01% 5898